로딩 중…
지수 로딩 중…
Centessa Pharmaceuticals plc
CNTA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
GB
$40.02+0.38%
2026-06-18
Price Chart
Centessa Pharmaceuticals plc+215.62%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $6.19B |
| Revenue | $0.00 |
| Net Income | $-251M |
| Total Assets | $642M |
| Net Assets | $487M |
| Value | |
| P/B | 12.71x |
| FCF Yield | -3.38% |
| Profitability | |
| ROE | -51.43% |
| ROA | -39.05% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 31.68% |
| Total Debt | $7M |
| FCF | $-209M |
| Cash | $62M |
| Current Ratio | 9.53x |
| Performance | |
| 1Y Return | 215.62% |
| 1M Return | 0.81% |
| From 52W High | -0.57% |
| 1Y MDD | -26.38% |
| Trading | |
| Volume | 5,513,059 shares |
| Trading Value | $220M |
| Per Share | |
| EPS | $-1.46 |
| BPS | $3.88 |